{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:07:14Z","timestamp":1790719634157,"version":"4.1.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1097\/ftd.0b013e3182666c62","type":"journal-article","created":{"date-parts":[[2012,8,28]],"date-time":"2012-08-28T10:06:40Z","timestamp":1346148400000},"page":"489-492","source":"Crossref","is-referenced-by-count":41,"title":["A Puzzling Case of Increased Serum Clozapine Levels in a Patient With Inflammation and Infection"],"prefix":"10.1097","volume":"34","author":[{"given":"Ketil Arne","family":"Espnes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kent Ove","family":"Heimdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olav","family":"Spigset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210129","first-page":"415","article-title":"Does level of care, gender, age or choice of drug influence adherence to treatment with antipsychotics J Clin Psychopharmacol.","volume":"29","author":"Castberg","year":"2009","journal-title":""},{"key":"R2-2-20210129","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00228-002-0486-x","article-title":". Bacterial pneumonia can increase serum concentration of clozapine.","volume":"58","author":"Raaska","year":"2002","journal-title":"Eur J Clin Pharmacol"},{"key":"R3-2-20210129","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0278-5846(03)00148-9","article-title":"Serious respiratory infections can increase clozapine levels and contribute to side effects: a case report.","volume":"27","author":"De Leon","year":"2003","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R4-2-20210129","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s00228-004-0867-4","article-title":". Toxic clozapine serum levels during acute urinary tract infection: a case report.","volume":"60","author":"Jecel","year":"2005","journal-title":"Eur J Clin Pharmacol"},{"key":"R5-2-20210129","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0924-977X(03)00042-7","article-title":". Toxic rise of clozapine plasma concentrations in relation to inflammation.","volume":"13","author":"Haack","year":"2003","journal-title":"Eur Neuropsychopharmacol"},{"key":"R6-2-20210129","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.4088\/JCP.v65n0818a","article-title":"Respiratory infections rather that antibiotics may increase clozapine levels: a critical review of the literature.","volume":"65","author":"De Leon","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"R7-2-20210129","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s002280100375","article-title":"Effect of influenza vaccination on serum clozapine and its main metabolite concentrations in patients with schizophrenia.","volume":"57","author":"Raaska","year":"2001","journal-title":"Eur J Clin Pharmacol"},{"key":"R8-2-20210129","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev.pharmtox.46.120604.141059","article-title":"Regulation of drug-metabolising enzymes and transporters in inflammation.","volume":"46","author":"Aitken","year":"2006","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"R9-2-20210129","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1053\/jhep.2000.8532","article-title":". Hepatic cytochrome P450 down-regulation during aseptic inflammation in the mouse is interleukin-6 dependent.","volume":"32","author":"Siewert","year":"2000","journal-title":"Hepatology"},{"key":"R10-2-20210129","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1046\/j.1365-2125.1998.00822.x","article-title":". Pharmacokinetics of clozapine and its metabolites in psychiatric patients: plasma protein binding and renal clearance.","volume":"46","author":"Schaber","year":"1998","journal-title":"Br J Clin Pharmacol"},{"key":"R11-2-20210129","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1124\/dmd.108.023671","article-title":". Interindividual variation in relative CYP1A23A4 phenotype influences susceptibility of clozapine oxidation to cytochrome P450-specific inhibition in human hepatic micorsomes.","volume":"36","author":"Zhang","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"R12-2-20210129","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.toxlet.2010.06.003","article-title":". Pregnane X receptor is required for interleukin-6 mediated downregulation of cytochrome P450 3A4 in human hepatocytes.","volume":"197","author":"Yang","year":"2010","journal-title":"Toxicol Lett"},{"key":"R13-2-20210129","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1124\/dmd.111.038679","article-title":". Effects of interleukin-6 (IL-6) and an anti-IL-6 monoclonal antibody on drug-metabolizing enzymes in human hepatocyte culture.","volume":"39","author":"Dickmann","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"R14-2-20210129","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1054\/jcaf.2002.127773","article-title":". Plasma levels of TNF- and IL-6 are inversely related to cytochrome P450-dependent drug metabolism in patients with congestive heart failure.","volume":"8","author":"Frye","year":"2002","journal-title":"J Card Fail"},{"key":"R15-2-20210129","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1176\/ajp.154.6.881a","article-title":". Fluoroqionlone inhibition of clozapine metabolism.","volume":"154","author":"Markowitz","year":"1997","journal-title":"Am J Psychiatry"},{"key":"R16-2-20210129","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s00228-007-0313-5","article-title":"Interaction of clozapine and ciprofloxacin: a case report.","volume":"63","author":"Samhi","year":"2007","journal-title":"Eur J Clin Pharmacol"},{"key":"R17-2-20210129","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2165\/0044011-200929010-00006","article-title":". Ciprofloxacin strongly inhibits clozapine metabolism.","volume":"29","author":"Brouwers","year":"2009","journal-title":"Clin Drug Investig"},{"key":"R18-2-20210129","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s002280000192","article-title":"Ciprofloxacin increases serum clozapine and N-desmethylclozapine: a study in patients with schizophrenia.","volume":"56","author":"Raaska","year":"2000","journal-title":"Eur J Clin Pharmacol"},{"key":"R19-2-20210129","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1600-0773.1999.tb02016.x","article-title":". Clozapine serum concentrations are lower in smoking than in non-smoking schizophrenic patients.","volume":"85","author":"Seppala","year":"1999","journal-title":"Pharmacol Toxicol"},{"key":"R20-2-20210129","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1345\/aph.1M398","article-title":"Impact of tobacco smoking cessation of stable clozapine or olanzapine treatment.","volume":"44","author":"Lowe","year":"2010","journal-title":"Ann Pharmacother"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0b013e3182666c62","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:39:57Z","timestamp":1620952797000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007691-201210000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0b013e3182666c62","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}